{"id":"W3055458153","doi":"10.1186/s12885-020-07252-y","title":"Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study","year":2020,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Stand Up To Cancer; National Cancer Institute; National Institutes of Health; Maag Lever Darm Stichting; ZonMw; Health~Holland; Mark Foundation For Cancer Research; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Newfoundland and Labrador; Commonwealth Foundation","keywords":"Medicine; Colorectal cancer; Internal medicine; Oxaliplatin; Oncology; Capecitabine; Cohort; Clinical trial; Clinical endpoint; Surgical oncology; Stage (stratigraphy); Cancer; Prospective cohort study; Randomized controlled trial; Surgery","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03327527,0.005304805,0.006991761,0.001390692,0.003160043,0.004008408,0.003191157,0.006393123,0.05365525],"category_scores_gemma":[0.03063379,0.002788702,0.004078146,0.002306235,0.003299054,0.002964215,0.002217288,0.007008934,0.01449544],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004522919,"about_ca_system_score_gemma":0.01578475,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001586112,"about_ca_topic_score_gemma":0.003784841,"domain_scores_codex":[0.9841016,0.00999106,0.001629597,0.001624758,0.001227436,0.001425496],"domain_scores_gemma":[0.9853242,0.00350753,0.003158769,0.002694109,0.002593364,0.002722045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8861116,0.0128921,0.001399585,0.01705899,0.001816788,0.0004924005,0.0005067756,0.002147638,0.004217648,0.005763206,0.03768047,0.02991297],"study_design_scores_gemma":[0.847457,0.04489021,0.003810146,0.00483846,0.001145058,0.0001715176,0.0001600823,0.001781085,0.001175932,0.004562344,0.08984871,0.0001595479],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.002491451,0.0005078896,0.001863199,0.0003890207,0.0004984149,0.9913636,0.00156696,0.0001154073,0.001204017],"genre_scores_gemma":[0.001702646,0.0001888365,0.001820717,0.0002337517,0.00008354552,0.9952428,0.0002751136,0.000008756751,0.0004438083],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.05365525,"threshold_uncertainty_score":0.1794947,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05663713047952291,"score_gpt":0.3786883287511034,"score_spread":0.3220511982715805,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}